prednisolone has been researched along with Bigfoot Disease in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shirai, K | 1 |
| Ito, T | 1 |
| Mitsuhashi, Y | 1 |
| Tsuboi, R | 1 |
| Sendhil Kumaran, M | 1 |
| Dutta, P | 1 |
| Sakia, U | 1 |
| Dogra, S | 1 |
2 other studies available for prednisolone and Bigfoot Disease
| Article | Year |
|---|---|
Dramatic effect of low-dose oral steroid on elephantiasic pretibial myxedema.
Topics: Adult; Elephantiasis; Glucocorticoids; Humans; Leg Dermatoses; Male; Myxedema; Prednisolone | 2014 |
Long-term follow-up and epidemiological trends in patients with pretibial myxedema: an 11-year study from a tertiary care center in northern India.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Clobetasol; Drug Therapy, Combination; | 2015 |